HTA funding trial into borderline personality disorders

The National Institute for Health Research Health Technology Assessment (NIHR HTA) Programme is funding the first large-scale NHS clinical trial of a drug therapy in borderline personality disorders.The LABILE (lamotrigine and borderline personality disorder: investigating long term effectiveness) study aims to establish whether lamotrigine, a mood stabiliser, is a worthwhile treatment when balancing the...
Source: NIHR Evaluation, Trials and Studies News - Category: American Health Source Type: news